• Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=22669776).
  
• Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Gly370Cys (c.1108G>T); ClinVar=VCV000016359; Zygosity=Unspecified (PubMed=22669776).
  

PubMed=22669776; DOI=10.1007/s13402-012-0082-8
Koch A., Hatina J., Rieder H., Seifert H.-H., Huckenbeck W., Jankowiak F., Florl A.R., Stoehr R., Schulz W.A.
Discovery of TP53 splice variants in two novel papillary urothelial cancer cell lines.
Cell. Oncol. (Dordr.) 35:243-257(2012)

PubMed=25997541; DOI=10.1186/s12864-015-1450-3; PMCID=PMC4470036
Earl J., Rico D., Carrillo-de-Santa-Pau E., Rodriguez-Santiago B., Mendez-Pertuz M., Auer H., Gomez G., Grossman H.B., Pisano D.G., Schulz W.A., Perez-Jurado L.A., Carrato A., Theodorescu D., Chanock S.J., Valencia A., Real F.X.
The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies.
BMC Genomics 16:403.1-403.16(2015)

PubMed=29732388; DOI=10.3233/BLC-180167; PMCID=PMC5929350
Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.
Systematic review: characteristics and preclinical uses of bladder cancer cell lines.
Bladder Cancer 4:169-183(2018)